Updated view on CVP's new analyst program?

After looking on LinkedIn and talking to a couple of people that are going there for summer '25, it seems as if CVP's analyst program is no longer a generalist across M&A/RX. Instead, they now have you pick a "major" and you then focus on either RX or M&A. That being said, I have a couple of questions:

1. Is the M&A route more prestigious and a better experience overall due to CVP's expertise in that? 

2. How is CVP's RX group? I know its not viewed as highly as other RX shops on here, but I'd actually argue that they land some sick deals due to their M&A connections

3. If someone wants to do RX, do you think they will still get looks from all the top exits after their 3 years since CVP RX is not a top tier RX shop

4. I know CVP is known for their M&A, so that being said, what does that mean for all the analysts that choose the RX route? Will that experience not be nearly as good or prestigious as CVP's analyst program has been in the past? 

Maybe I am overthinking this whole new structure, and analysts will still be able to get staffed on M&A deals if they want to and vice versa. I am just curious on how this will impact incoming analysts and whether CVP's analyst program will continue to be such a good experience regardless of the "major" one decides to pick. 

All insights are appreciated, thanks. 

7 Comments
 

They definitely have some pretty smart people in their rx group. however stop worrying abt prestige, CVP is a great place for career banking regardless of the group.

Worry abt getting an offer first

 

Praesentium provident voluptate molestiae est. Similique nobis et sed incidunt iusto nihil sequi. Ducimus earum consequatur facilis et omnis eum nostrum.

Totam totam dignissimos consequatur velit ea voluptatem eveniet. Nihil illo natus sunt quo aliquid. Consequatur minima vero odit voluptates.

Tempore unde est repudiandae repellat et iste. Voluptatum veritatis est quia et. Id consequatur autem dignissimos asperiores rerum. Autem expedita totam et dolorem quod corrupti neque facere. Autem tempora aut dolor qui. Corporis reprehenderit nam quia fuga.

Reiciendis iusto harum iure voluptate rerum et sit. Fugiat consequuntur explicabo voluptas quam dicta iusto sequi. Sint aut ut blanditiis ut.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”